SIGA Technologies (SIGA) Stock Analysis

What SIGA Technologies does

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

Key metrics

ETFs linked to SIGA

Broad-market and Healthcare sector ETFs an investor holding SIGA Technologies is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SIGA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for SIGA Technologies?

SIGA Technologies trades under the ticker SIGA on NASDAQ.

Which exchange is SIGA listed on?

SIGA is listed on NASDAQ.

What sector does SIGA Technologies operate in?

SIGA Technologies is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze SIGA in a portfolio?

PortView shows SIGA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.